These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 24894645)
1. Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery. Kim HA; Nam K; Kim SW Biomaterials; 2014 Aug; 35(26):7543-52. PubMed ID: 24894645 [TBL] [Abstract][Full Text] [Related]
2. Design of PEI-conjugated bio-reducible polymer for efficient gene delivery. Nam JP; Kim S; Kim SW Int J Pharm; 2018 Jul; 545(1-2):295-305. PubMed ID: 29698820 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of dendrimer type bio-reducible polymer as a siRNA delivery carrier for cancer therapy. Nam JP; Nam K; Jung S; Nah JW; Kim SW J Control Release; 2015 Jul; 209():179-85. PubMed ID: 25937533 [TBL] [Abstract][Full Text] [Related]
4. Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy. Choi JW; Kim HA; Nam K; Na Y; Yun CO; Kim S J Control Release; 2015 Dec; 220(Pt B):691-703. PubMed ID: 26437261 [TBL] [Abstract][Full Text] [Related]
5. Active targeting of RGD-conjugated bioreducible polymer for delivery of oncolytic adenovirus expressing shRNA against IL-8 mRNA. Kim J; Nam HY; Kim TI; Kim PH; Ryu J; Yun CO; Kim SW Biomaterials; 2011 Aug; 32(22):5158-66. PubMed ID: 21531456 [TBL] [Abstract][Full Text] [Related]
6. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
7. Post-translational regulation of a hypoxia-responsive VEGF plasmid for the treatment of myocardial ischemia. Won YW; McGinn AN; Lee M; Nam K; Bull DA; Kim SW Biomaterials; 2013 Aug; 34(26):6229-38. PubMed ID: 23714244 [TBL] [Abstract][Full Text] [Related]
8. Dendrimer type bio-reducible polymer for efficient gene delivery. Nam HY; Nam K; Lee M; Kim SW; Bull DA J Control Release; 2012 Jun; 160(3):592-600. PubMed ID: 22546681 [TBL] [Abstract][Full Text] [Related]
9. PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy. Kim J; Kim SW; Kim WJ Oligonucleotides; 2011; 21(2):101-7. PubMed ID: 21375397 [TBL] [Abstract][Full Text] [Related]
10. VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine). Kim SH; Jeong JH; Kim TI; Kim SW; Bull DA Mol Pharm; 2009; 6(3):718-26. PubMed ID: 19055368 [TBL] [Abstract][Full Text] [Related]
11. VEGF therapeutic gene delivery using dendrimer type bio-reducible polymer into human mesenchymal stem cells (hMSCs). Kim H; Nam K; Nam JP; Kim HS; Kim YM; Joo WS; Kim SW J Control Release; 2015 Dec; 220(Pt A):222-228. PubMed ID: 26368313 [TBL] [Abstract][Full Text] [Related]
12. Novel guanidinylated bioresponsive poly(amidoamine)s designed for short hairpin RNA delivery. Yu J; Zhang J; Xing H; Sun Y; Yang Z; Yang T; Cai C; Zhao X; Yang L; Ding P Int J Nanomedicine; 2016; 11():6651-6666. PubMed ID: 27994462 [TBL] [Abstract][Full Text] [Related]
13. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy. Lu ZX; Liu LT; Qi XR Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456 [TBL] [Abstract][Full Text] [Related]
14. RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment. Yonenaga N; Kenjo E; Asai T; Tsuruta A; Shimizu K; Dewa T; Nango M; Oku N J Control Release; 2012 Jun; 160(2):177-81. PubMed ID: 22019557 [TBL] [Abstract][Full Text] [Related]
15. Integrin targeting using RGD-PEI conjugates for in vitro gene transfer. Kunath K; Merdan T; Hegener O; Häberlein H; Kissel T J Gene Med; 2003 Jul; 5(7):588-99. PubMed ID: 12825198 [TBL] [Abstract][Full Text] [Related]
16. Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA. Beloor J; Choi CS; Nam HY; Park M; Kim SH; Jackson A; Lee KY; Kim SW; Kumar P; Lee SK Biomaterials; 2012 Feb; 33(5):1640-50. PubMed ID: 22112761 [TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte-targeted siRNA delivery by prostaglandin E(2)-Fas siRNA polyplexes formulated with reducible poly(amido amine) for preventing cardiomyocyte apoptosis. Kim SH; Jeong JH; Ou M; Yockman JW; Kim SW; Bull DA Biomaterials; 2008 Nov; 29(33):4439-46. PubMed ID: 18725170 [TBL] [Abstract][Full Text] [Related]
18. Enhanced siRNA delivery using a combination of an arginine-grafted bioreducible polymer, ultrasound, and microbubbles in cancer cells. Florinas S; Nam HY; Kim SW Mol Pharm; 2013 May; 10(5):2021-30. PubMed ID: 23527953 [TBL] [Abstract][Full Text] [Related]
19. Delivery of siRNA mediated by histidine-containing reducible polycations. Stevenson M; Ramos-Perez V; Singh S; Soliman M; Preece JA; Briggs SS; Read ML; Seymour LW J Control Release; 2008 Aug; 130(1):46-56. PubMed ID: 18571758 [TBL] [Abstract][Full Text] [Related]
20. A novel dendritic nanocarrier of polyamidoamine-polyethylene glycol-cyclic RGD for "smart" small interfering RNA delivery and in vitro antitumor effects by human ether-à-go-go-related gene silencing in anaplastic thyroid carcinoma cells. Li G; Hu Z; Yin H; Zhang Y; Huang X; Wang S; Li W Int J Nanomedicine; 2013; 8():1293-306. PubMed ID: 23569377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]